NCT00003478View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Brain and Central Nervous System Tumors

Interventions

PROCEDURE

conventional surgery

RADIATION

iodine I 131 monoclonal antibody 81C6

RADIATION

radiation therapy

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER